FREE Account Opening + No Clearing Fees
Loading...

Evoq Remedies IPO vs Swaraj Suiting IPO

Comparision between Evoq Remedies IPO and Swaraj Suiting IPO.

IPO Details

Evoq Remedies IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Swaraj Suiting IPO is a SME Fixed Price Issue proposed to list at NSE SME.

  Evoq Remedies IPO Swaraj Suiting IPO
Logo Evoq Remedies IPO Logo Swaraj Suiting IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME NSE SME
Lead Managers Swastika Investmart Ltd Finshore Management Services Limited
Registrar Bigshare Services Pvt Ltd Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Evoq Remedies IPO is up to ₹9.72 Cr whereas the issue size of the Swaraj Suiting IPO is up to ₹10.68 Cr. The final issue price of Evoq Remedies IPO is ₹27.00 per share and of Swaraj Suiting IPO is ₹56.00 per share.

  Evoq Remedies IPO Swaraj Suiting IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹27.00 per share ₹56.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 4000 shares 2000 shares
Fresh Issue Size 36,00,000 shares 19,08,000 shares
Fresh Issue Size (Amount) up to ₹9.72 Cr up to ₹10.68 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 36,00,000 shares 19,08,000 shares
Issue Size Total (Amount) up to ₹9.72 Cr up to ₹10.68 Cr

IPO Timetable

Evoq Remedies IPO opens on Mar 17, 2022, while Swaraj Suiting IPO opens on Mar 15, 2022. The closing date of Evoq Remedies IPO and Swaraj Suiting IPO is Mar 22, 2022, and Mar 17, 2022, respectively.

  Evoq Remedies IPO Swaraj Suiting IPO
Anchor Bid Date
Issue Open Mar 17, 2022 Mar 15, 2022
Issue Close Mar 22, 2022 Mar 17, 2022
Basis Of Allotment (Tentative) Mar 25, 2022 Mar 23, 2022
Initiation of Refunds (Tentative) Mar 28, 2022 Mar 24, 2022
Credit of Share (Tentative) Mar 29, 2022 Mar 25, 2022
Listing date (Tentative) Mar 30, 2022 Mar 28, 2022
Anchor Lockin End date 1 Apr 24, 2022 Apr 22, 2022
Anchor Lockin End date 2 Jun 23, 2022 Jun 21, 2022

Financials

Evoq Remedies IPO P/E ratio is 33.75, as compared to Swaraj Suiting IPO P/E ratio of 10.55.

  Evoq Remedies IPO Swaraj Suiting IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in Lakh)
  10-Feb-22 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 2660.58 804.63 565.22 214.78
Total Revenue 1056.58 1002.48 907.21 325
Profit After Tax 93.67 71.38 0.03 1.11
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in million)
  30-Sep-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 916.23 917.17 970.45 937.34
Total Revenue 817.19 602.16 806.53 764.17
Profit After Tax 19.10 26.75 35.43 21.86
Promoter Shareholding (Pre-Issue) 99.99% 99.74%
Promoter Shareholding (Post-Issue) 73.53% 73.31%
P/E Ratio 33.75 10.55
Market Cap ₹36.72 Cr. ₹40.32 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Evoq Remedies IPO retail investors (RII) are offered 17,10,000 shares while in Swaraj Suiting IPO retail investors are offered 17,10,000 shares. Qualified institutional buyers (QIB) are offered in Evoq Remedies IPO and in Swaraj Suiting IPO.

  Evoq Remedies IPO Swaraj Suiting IPO
Anchor Investor Reserveration
Market Maker Reserveration 1,80,000 shares 96,000 shares
QIB
NII 17,10,000 shares 9,04,000 shares
RII 17,10,000 shares 9,08,000 shares
Employee
Others
Total 34,20,000 shares 18,12,000 shares

Bids Received (Subscription)

Evoq Remedies IPO subscribed 1.67x in total, whereas Swaraj Suiting IPO subscribed 12.13x.

  Evoq Remedies IPO Swaraj Suiting IPO
QIB (times)
NII (times) 0.30x 13.81x
Big NII (times)
Small NII (times)
RII (times) 3.03x 10.46x
Employee (times)
Other (times)
Total (times) 1.67x 12.13x

Comments

Add a public comment...